May 22, 2020 Price forecast | 2 weeks: 0.87% | 1 month: -0.42% | 3 months: -5.16%


VXRT stock forecast

Our latest prediction for Vaxart Inc's stock price was made on the May 22, 2020 when the stock price was at 2.91$.

In the short term (2weeks), VXRT's stock price should outperform the market by 0.87%. During that period the price should oscillate between -12.74% and +17.02%.

In the medium term (3months), VXRT's stock price should underperform the market by -5.16%. During that period the price should oscillate between -39.99% and +37.39%.

Create a solid portfolio with VXRT

Add VXRT to your portfolio and optimize it!


About Vaxart Inc

Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. Vaxart has a collaborative development program for oral delivery of a vaccine against universal flu using proprietary antigens from Janssen Pharmaceutica .

At the moment the company generates 7M USD in revenues.

On its last earning announcement, the company reported a loss of -0.70$ per share.

The book value per share is 3.13$

Vaxart Inc website


Three months stock forecastMay 22, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
7M 100.00% -11M -150.19% -19M -0.70 - - 35M 3.13 -12M - -12M